Dudediligence.

Incyte Corporation

INCYNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.14BSep ’24$1.18BDec ’24$1.05BMar ’25$1.22BJun ’25$1.37BSep ’25$1.51BDec ’25$1.27BMar ’26$1.67BJun ’26
Net income, by quarter
$106.5MSep ’24$201.2MDec ’24$158.2MMar ’25$405.0MJun ’25$424.2MSep ’25$299.3MDec ’25$303.3MMar ’26$585.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.99B$3.39B$3.70B$4.24B$5.14B
Gross profit$2.84B$3.19B$3.44B$3.93B$4.77B
Operating income$585.8M$579.4M$620.5M$61.4M$1.51B
Net income$948.6M$340.7M$597.6M$32.6M$1.29B
Operating cash flow$749.5M$969.9M$496.5M$335.3M$1.41B
Free cash flow$568.5M$892.1M$464.0M$249.1M$1.35B
Cash$2.06B$2.95B$3.21B$1.69B$3.10B
Shares outstanding221.1M222.7M224.3M193.4M198.5M